Cancer incidence, morbidity and mortality in the Commonwealth of Kentucky are among the highest in the nation. The James Graham Brown Cancer Center's mission is to reduce cancer incidence, morbidity and mortality particularly within the Commonwealth and the region we serve. The clinical and research programs of the James Graham Brown Cancer Center have experienced tremendous growth in faculty recruitment, and in the development of scientific and clinical programs and shared use facilities. The long-term objective of the University of Louisville Cancer Education Program is to recruit, educate and motivate outstanding undergraduate and professional students to pursue further training and future careers in cancer research. The program fits exceptionally well within the strategic plans of the University of Louisville and we will implement novel recruitment, evaluation, and dissemination strategies to achieve the objectives of the program.

Public Health Relevance

Cancer incidence, morbidity and mortality in the Commonwealth of Kentucky are among the highest in the nation. The James Graham Brown Cancer Center's mission is to reduce cancer incidence, morbidity and mortality particularly within the Commonwealth and the region we serve. The clinical and research programs of the James Graham Brown Cancer Center have experienced tremendous growth in faculty recruitment, and in the development of scientific and clinical programs and shared use facilities. The long-term objective of the University of Louisville Cancer Education Program is to recruit, educate and motivate outstanding undergraduate and professional students to pursue further training and future careers in cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Education Projects (R25)
Project #
5R25CA134283-03
Application #
8540828
Study Section
Subcommittee G - Education (NCI)
Program Officer
Korczak, Jeannette F
Project Start
2011-09-14
Project End
2016-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
3
Fiscal Year
2013
Total Cost
$296,645
Indirect Cost
$21,974
Name
University of Louisville
Department
Pharmacology
Type
Schools of Medicine
DUNS #
057588857
City
Louisville
State
KY
Country
United States
Zip Code
40292
Hein, David W; Kidd, La Creis R (2018) Design and Success of a 21st Century Cancer Education Program at the University of Louisville. J Cancer Educ 33:298-308
Hein, David W; Fakis, Giannoulis; Boukouvala, Sotiria (2018) Functional expression of human arylamine N-acetyltransferase NAT1*10 and NAT1*11 alleles: a mini review. Pharmacogenet Genomics 28:238-244
Carlisle, Samantha M; Trainor, Patrick J; Doll, Mark A et al. (2018) Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity. Mol Carcinog 57:1458-1466
Xiao, Jingjing; Egger, Michael E; McMasters, Kelly M et al. (2018) Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines. BMC Cancer 18:675
Samykutty, Abhilash; Grizzle, William E; Fouts, Benjamin L et al. (2018) Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle. Biomaterials 182:114-126
Hein, David W; Hollenberg, Paul F; McQueen, Charlene A et al. (2018) In memoriam: Wendell W. Weber, PhD, MD (1925-2018). Pharmacogenet Genomics 28:177-178
Garza-Morales, Rodolfo; Gonzalez-Ramos, Roxana; Chiba, Akiko et al. (2018) Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro. Cancers (Basel) 10:
Jones, Dominique Z; Schmidt, M Lee; Suman, Suman et al. (2018) Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells. BMC Cancer 18:421
Bardi, Gina T; Smith, Mary Ann; Hood, Joshua L (2018) Melanoma exosomes promote mixed M1 and M2 macrophage polarization. Cytokine 105:63-72
Heitz, Adaline E; Baumgartner, Richard N; Baumgartner, Kathy B et al. (2018) Healthy lifestyle impact on breast cancer-specific and all-cause mortality. Breast Cancer Res Treat 167:171-181

Showing the most recent 10 out of 43 publications